Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
san francisco blog main
san francisco top stories
allergan
boston blog main
boston top stories
bristol-myers squibb
cannabidiol
clinical data
dravet syndrome
drugs
epidiolex
fda
fen-phen
fenfluramine
genfit
gilead sciences
gw pharmaceuticals
intercept pharmaceuticals
ldl-c
lennox-gastaut syndrome
liver
liver disease
madrigal pharmaceuticals
mark pruzanski
nash
national top stories
new york
new york blog main
new york top stories
nonalcoholic steatohepatitis
obeticholic acid
san diego blog main
san diego top stories
san francisco
viking therapeutics
zogenix
What
approved
2
×
data
2
×
drug
medicine
2
×
ago
battle
cannabis
derivative
disease
epilepsy
fatty
fda
form
gw
gw’s
horizon
intercept
known
liver
marijuana
market
marketed
nash
new
nonalcoholic
pharmaceuticals
rare
sets
steatohepatitis
track
weeks
zogenix
Language
Current search:
approved
×
medicine
×
data
×
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug
